Here begins the text.

JP Drafts (December 2021)

JP drafts for public comments, December 1, 2021 - February 28, 2022

New monographs (Crude drug)
Removing Heavy Metals Test and Individual Metal Impurity Test from Japanese Pharmacopoeia (JP) Official Monographs, accompanying the application of Control of Elemental Impurities in the Japanese Phrmacopoeia 18th Edition (JP18)

Please refer to the Briefing Note as well.


To send the comment on these drafts, the guidance is as follows:

  1. Download the form for comments in  Word format
  2. Fill in the form
  3. Prepare and attach the supportive data that scientifically validate the comment when appropriate
  4. Send it to the email address: JPdraft-engpmda.go.jp

Note:
For the purpose of security, this email address is partly incorrect. Please replace with @ when sending an email.

Related Information
 

Note:
The information submitted with the comments may be released to the public whenever necessary (except the individual name, organization, address, telephone & fax numbers and e-mail address or the attached supportive data).
Your comments will be considered for the preparation of JP final drafts, but no individual response will be made to each comment.

JCN 3010005007409

Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki,
Chiyoda-ku, Tokyo 100-0013 Japan

  • Contact us
  • Access/Map

Copyright (C) Pharmaceuticals and Medical Devices Agency, All Rights Reserved.

000048833
0
JP Drafts (December 2021)
/english/rs-sb-std/standards-development/jp/pub-comments/jp/0031.html
en